International Neuromodulation Society Critical Assessment: Guideline Review of Implantable Neurostimulation Devices

Deer, Timothy R.; Thomson, Simon; Pope, Jason E.; Russo, Marc; Luscombe, F. E.; Levy, Robert M.

doi:10.1111/ner.12186

Cited by 17 publications

(8 citation statements)

References 41 publications

(46 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Finding efficacious, long‐term treatment for CRPS has been difficult . One of the more successful treatment modalities has been traditional tonic spinal cord stimulation (SCS), which has proven to significantly improve the quality of life and decrease pain in some of these patients . However, this treatment was not ideal insofar as it tended to induce paresthesia in areas outside of the regions affected by the syndrome, loss of effectiveness over time, inconsistent coverage of affected areas, and the risk of lead breakage and migration.…”

Section: Introductionmentioning

confidence: 99%

Single S1 Dorsal Root Ganglia Stimulation for Intractable Complex Regional Pain Syndrome Foot Pain After Lumbar Spine Surgery: A Case Series

Skaribas

Peccora

Skaribas

2019

Neuromodulation: Technology at the Neural Interface

View full text Add to dashboard Cite

Section: Introductionmentioning

confidence: 99%

Single S1 Dorsal Root Ganglia Stimulation for Intractable Complex Regional Pain Syndrome Foot Pain After Lumbar Spine Surgery: A Case Series

Skaribas

Peccora

Skaribas

2019

Neuromodulation: Technology at the Neural Interface

View full text Add to dashboard Cite

“…Spinal cord stimulation (SCS) has been successfully utilized in the treatment of a diverse and increasing number of painful conditions including failed back surgery syndrome (FBSS), complex regional pain syndrome (CRPS), diabetic peripheral neuropathy (DPN), and radiculopathy without evidence of a disk herniation (1)(2)(3). As the technology is refined and the indications continue to expand, there is a need to better understand the mechanism of action and prognostication of SCS therapy outcomes.…”

Section: Introductionmentioning

confidence: 99%

Neuropathic Pain Medication Use Does Not Alter Outcomes of Spinal Cord Stimulation for Lower Extremity Pain

Maher

Martins

Doshi

et al. 2018

Neuromodulation: Technology at the Neural Interface

View full text Add to dashboard Cite

show abstract

“…Initial indications for spinal cord stimulation were chronic pain of the trunk and limbs caused by unremitting pain from nerve damage 1 . However, a recent international panel recommended consideration of neurostimulation across a wide scope of conditions, including post‐laminectomy syndrome, complex regional pain syndrome, chronic low back or neck pain with radiculopathy, chronic neuropathic pain, chronic visceral pain, post‐cancer treatment pain, and refractory angina pectoris 2 . This expansion of clinical indications has been met with an explosive evolution of novel implantable neuromodulation technologies within an already competitive marketplace.…”

Section: Case Scenariomentioning

confidence: 99%

Conventional versus High‐Frequency Neuromodulation in the Treatment of Low Back Pain Following Spine Surgery

Sclafani

Leong

Desai

et al. 2019

PM&R

View full text Add to dashboard Cite

A 54-year-old man presents with history of low back pain radiating to the right lateral leg as well as pain in the dorsum of the foot. He describes the symptoms as stabbing and burning. The symptoms began 5 years ago at which point he was treated with neuropathic medications, two rounds of epidural steroid injections, both transforaminal and interlaminar approaches, as well as physical therapy. Four years ago, the patient underwent an L4-S1 transforaminal lumbar interbody fusion for stenosis and neurogenic claudication. He did well for 3.5 years and reported 80% to 90% relief during that time. He now presents with recurrence of primarily low back pain (90%) with minimal right leg pain. Updated imaging reveals stable hardware and no evidence of adjacent segment disease. The spinal canal is patent and there is mild foraminal stenosis at L4-5 and L5-1. Both a caudal epidural steroid injection and sacroiliac joint injections were unsuccessful. Currently the patient is taking 50 mg morphine equivalent daily and gabapentin and baclofen. Electrodiagnostics demonstrate chronic mild right L5 radiculopathy. The patient has read about spinal cord stimulation online and is interested in learning more about this therapy modality. You first address his psychological profile through a formal evaluation and no red flags are noted that would preclude proceeding. Drs. Joseph Sclafani and Michael Leong will argue that conventional neurostimulation has a proven track record of success and this modality will offer this patient the best coverage of his pain. Drs. Mehul Desai, Neel Mehta, and Dawood Sayed will argue that new waveform high-frequency (HF) stimulation is more likely to provide this patient with pain relief and functional improvement.

show abstract

International Neuromodulation Society Critical Assessment: Guideline Review of Implantable Neurostimulation Devices

Cited by 17 publications

References 41 publications

Single S1 Dorsal Root Ganglia Stimulation for Intractable Complex Regional Pain Syndrome Foot Pain After Lumbar Spine Surgery: A Case Series

Single S1 Dorsal Root Ganglia Stimulation for Intractable Complex Regional Pain Syndrome Foot Pain After Lumbar Spine Surgery: A Case Series

Neuropathic Pain Medication Use Does Not Alter Outcomes of Spinal Cord Stimulation for Lower Extremity Pain

Conventional versus High‐Frequency Neuromodulation in the Treatment of Low Back Pain Following Spine Surgery

Contact Info

Product

Resources

About